Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-013892
Filing Date
2017-05-19
Accepted
2017-05-19 16:05:33
Documents
1
Period of Report
2017-05-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7166
  Complete submission text file 0000899243-17-013892.txt   8685
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Issuer) CIK: 0001512762 (see all company filings)

EIN.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 5375 MEDPACE WAY CINCINNATI OH 45227
Business Address
Troendle August J. (Reporting) CIK: 0001622058 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36721 | Film No.: 17857832